Breakthrough cancer pain treatment in Spain: physicians’ perception of current opioids utilization and prescription

References

• Portenoy RK, Payne D, Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain. Pain. 1999;81(1–2):129–134.
   PubMed Web of Science ®Google Scholar
• Davies AN, Dickman A, Reid C, et al. The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. Eur J Pain. 2009;13(4):331–338.
   PubMed Web of Science ®Google Scholar
• Davies A, Buchanan A, Zeppetella G, et al. Breakthrough cancer pain: an observational study of 1000 European oncology patients. J Pain Symptom Manage. 2013;46(5):619–628.
   PubMed Web of Science ®Google Scholar
• Hjermstad MJ, Kaasa S, Caraceni A, et al. Characteristics of breakthrough cancer pain and its influence on quality of life in an international cohort of patients with cancer. BMJ Support Palliat Care. 2016;6(3):344–352.
   PubMed Web of Science ®Google Scholar
• Mercadante S, Cuomo A. Breakthrough cancer pain: ten commandments. Value Health. 2016;19(5):531–536.
   PubMed Web of Science ®Google Scholar
• Caraceni A, Martini C, Zecca E, et al. Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey. Palliat Med. 2004;18(3):177–183.
   PubMed Web of Science ®Google Scholar
• Gomez-Batiste X, Madrid F, Moreno F, et al. Breakthrough cancer pain: prevalence and characteristics in patients in Catalonia, Spain. J Pain Symptom Manage. 2002;24(1):45–52.
   PubMed Web of Science ®Google Scholar
• Canal-Sotelo J, Trujillano-Cabello J, Larkin P, et al. Prevalence and characteristics of breakthrough cancer pain in an outpatient clinic in a Catalan teaching hospital: incorporation of the Edmonton Classification System for cancer pain into the diagnostic algorithm. BMC Palliat Care. 2018;17(1):81.
   PubMed Web of Science ®Google Scholar
• Deandrea S, Corli O, Consonni D, et al. Prevalence of breakthrough cancer pain: a systematic review and a pooled analysis of published literature. J Pain Symptom Manage. 2014;47(1):57–76.
   PubMed Web of Science ®Google Scholar
• Fallon M, Giusti R, Aielli F, et al. Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Annals of Oncology: Official Journal of the European Society for Medical Oncology. 2018;29(4):iv166–iv191.
   Web of Science ®Google Scholar
• Breivik H, Cherny N, Collett B, et al. Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol. 2009;20(8):1420–1433.
   PubMed Web of Science ®Google Scholar
• Estevez FV, Alarcon MDL, Mayoral V, et al. Current management of breakthrough cancer pain according to physicians from pain units in Spain. Clin Transl Oncol. 2019;21(9):1168–1176.
   PubMed Web of Science ®Google Scholar
• Zeppetella G, Ribeiro MD. Opioids for the management of breakthrough (episodic) pain in cancer patients. The Cochrane Database of Systematic Reviews. 2006;1:CD004311.
   Google Scholar
• Caraceni A, Hanks G, Kaasa S, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 2012;13(2):e58–e68.
   PubMed Web of Science ®Google Scholar
• Vellucci R, Fanelli G, Pannuti R, et al. What to do, and what not to do, when diagnosing and treating breakthrough cancer pain (BTcP): expert opinion. Drugs. 2016;76(3):315–330.
   PubMed Web of Science ®Google Scholar
• Pargeon KL, Hailey BJ. Barriers to effective cancer pain management: a review of the literature. J Pain Symptom Manage. 1999;18(5):358–368.
   PubMed Web of Science ®Google Scholar
• Graczyk M, Borkowska A, Krajnik M. Why patients are afraid of opioid analgesics: a study on opioid perception in patients with chronic pain. Polish Arch Internal Med. 2018;128(2):89–97.
   PubMedGoogle Scholar
• Margarit C, Juliá J, Lopez R, et al. Breakthrough cancer pain - still a challenge. J Pain Res. 2012;5:559–566.
   PubMedGoogle Scholar
• Greco MT, Corli O, Montanari M, et al. Epidemiology and pattern of care of breakthrough cancer pain in a longitudinal sample of cancer patients: results from the Cancer Pain Outcome Research Study Group. Clin J Pain. 2011;27(1):9–18.
   PubMed Web of Science ®Google Scholar
• Jara C, Del Barco S, Gravalos C, et al. Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. Clin Transl Oncol. 2018;20(1):97–107.
   PubMed Web of Science ®Google Scholar
• Davies AN, Elsner F, Filbet MJ, et al. Breakthrough cancer pain (BTcP) management: a review of international and national guidelines. BMJ Support Palliat Care. 2018;8(3):241–249.
   PubMed Web of Science ®Google Scholar
• Porta-Sales J, Perez C, Escobar Y, et al. Diagnosis and management of breakthrough cancer pain: have all the questions been resolved? A Delphi-based consensus assessment (DOIRON). Clin Translational Oncol. 2016;18(9):945–954.
   PubMed Web of Science ®Google Scholar
• Boceta J, De la Torre A, Samper D, et al. Consensus and controversies in the definition, assessment, treatment and monitoring of BTcP: results of a Delphi study. Clin Translational Oncol. 2016;18(11):1088–1097.
   PubMed Web of Science ®Google Scholar
• Berterame S, Erthal J, Thomas J, et al. Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study. Lancet. 2016;387(10028):1644–1656.
   PubMed Web of Science ®Google Scholar
• Kaye AD, Jones MR, Kaye AM, et al. Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse (Part 2). Pain Physician. 2017;20(2S):S111–S133.
   PubMed Web of Science ®Google Scholar
• Kaye AD, Jones MR, Kaye AM, et al. Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse: part 1. Pain Physician. 2017;20(2S):S93–S109.
   PubMed Web of Science ®Google Scholar
• Boudreau D, Von Korff M, Rutter CM, et al. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf. 2009;18(12):1166–1175.
   PubMed Web of Science ®Google Scholar
• Frieden TR, Houry D. Reducing the risks of relief-the CDC opioid-prescribing guideline. N Engl J Med. 2016;374(16):1501–1504.
   PubMed Web of Science ®Google Scholar
• Duthey B, Scholten W. Adequacy of opioid analgesic consumption at country, global, and regional levels in 2010, its relationship with development level, and changes compared with 2006. J Pain Symptom Manage. 2014;47(2):283–297.
   PubMed Web of Science ®Google Scholar
• Seya MJ, Gelders SF, Achara OU, et al. A first comparison between the consumption of and the need for opioid analgesics at country, regional, and global levels. J Pain Palliat Care Pharmacother. 2011;25(1):6–18.
   PubMedGoogle Scholar
• Kwon JH. Overcoming barriers in cancer pain management. J Clin Oncol. 2014;32(16):1727–1733.
   PubMed Web of Science ®Google Scholar
• Breuer B, Fleishman SB, Cruciani RA, et al. Medical oncologists’ attitudes and practice in cancer pain management: a national survey. J Clin Oncol. 2011;29(36):4769–4775.
   PubMed Web of Science ®Google Scholar
• Carulla Torrent J, Jara Sanchez C, Sanz Ortiz J, et al. Oncologists’ perceptions of cancer pain management in Spain: the real and the ideal. Eur J Pain. 2007;11(3):352–359.
   PubMed Web of Science ®Google Scholar
• Vallerand AH, Collins-Bohler D, Templin T, et al. Knowledge of and barriers to pain management in caregivers of cancer patients receiving homecare. Cancer Nurs. 2007;30(1):31–37.
   PubMed Web of Science ®Google Scholar
• Miaskowski C, Dodd MJ, West C, et al. Lack of adherence with the analgesic regimen: a significant barrier to effective cancer pain management. J Clin Oncol. 2001;19(23):4275–4279.
   PubMed Web of Science ®Google Scholar
• Bennett MI, Bagnall AM, Jose Closs S. How effective are patient-based educational interventions in the management of cancer pain? Systematic review and meta-analysis. Pain. 2009;143(3):192–199.
   PubMed Web of Science ®Google Scholar
• Nguyen LM, Rhondali W, De la Cruz M, et al. Frequency and predictors of patient deviation from prescribed opioids and barriers to opioid pain management in patients with advanced cancer. J Pain Symptom Manage. 2013;45(3):506–516.
   PubMed Web of Science ®Google Scholar
• Webber K, Davies AN, Cowie MR. Breakthrough pain: a qualitative study involving patients with advanced cancer. Support Care Cancer. 2011;19(12):2041–2046.
   PubMed Web of Science ®Google Scholar
• Rhiner MI, von Gunten CF. Cancer breakthrough pain in the presence of cancer-related chronic pain: fact versus perceptions of health-care providers and patients. J Support Oncol. 2010;8(6):232–238.
   PubMedGoogle Scholar